The microvascular partial pressure of oxygen (PmvO 2 ) kinetics following the onset of exercise reflects the relationship between muscle O2 delivery and uptake (V O2). Although AMP-activated protein kinase (AMPK) is known as a regulator of mitochondria and nitric oxide metabolism, it is unclear whether the dynamic balance of O2 delivery and V O2 at exercise onset is dependent on AMPK activation level. We used transgenic mice with muscle-specific AMPK dominant-negative (AMPK-DN) to investigate a role for skeletal muscle AMPK on PmvO 2 kinetics following onset of muscle contractions. Phosphorescence quenching techniques were used to measure PmvO 2 at rest and across the transition to twitch (1 Hz) and tetanic (100 Hz, 3-5 V, 4-ms pulse duration, stimulus duration of 100 ms every 1 s for 1 min) contractions in gastrocnemius muscles (each group n ϭ 6) of AMPK-DN mice and wild-type littermates (WT) under isoflurane anesthesia with 100% inspired O2 to avoid hypoxemia. Baseline PmvO 2 before contractions was not different between groups (P Ͼ 0.05). Both muscle contraction conditions exhibited a delay followed by an exponential decrease in PmvO 2 . However, compared with WT, AMPK-DN demonstrated 1) prolongation of the time delay before PmvO 2 began to decline (1 Hz: WT, 3.2 Ϯ 0.5 s; AMPK-DN, 6.5 Ϯ 0.4 s; 100 Hz: WT, 4.4 Ϯ 1.0 s; AMPK-DN, 6.5 Ϯ 1.4 s; P Ͻ 0.05), 2) a faster response time (i.e., time constant; 1 Hz: WT, 19.4 Ϯ 3.9 s; AMPK-DN, 12.4 Ϯ 2.6 s; 100 Hz: WT, 15.1 Ϯ 2.2 s; AMPK-DN, 9.0 Ϯ 1.7 s; P Ͻ 0.05). These findings are consistent with the presence of substantial mitochondrial and microvascular dysfunction in AMPK-DN mice, which likely slows O2 consumption kinetics (i.e., oxidative phosphorylation response) and impairs the hyperemic response at the onset of contractions thereby sowing the seeds for exercise intolerance.
cert with reduced exercise tolerance (45) . Previous studies have highlighted the importance of AMPK in the maintenance of [ATP] during muscle contractions (17, 25, 30, 44) . For example, skeletal muscle [ATP] decreases in muscle-specific AMPK dominant-negative (AMPK-DN) mice during running exercise compared with wild-type (WT) mice (25) .
Changes of [ATP] in AMPK-DN mice during muscle contractions reflects an impaired balance in the ATP utilization/ production pathways. There are O 2 -independent (phosphocreatine hydrolysis and glycolysis) and O 2 -dependent (mitochondrial) mechanisms of ATP resynthesis. It well known that the phosphocreatine hydrolysis and glycolysis pathways are activated with little or no delay at the onset of muscle contractions (10, 43) . On the other hand, there has been debate about whether muscle oxygen consumption (V O 2 ) begins to increase immediately following exercise onset (1, 11, 37, 40, 49) . The presence of a pronounced delay in the increase of V O 2 was reported across the exercising human leg muscle (2, 14, 22) and electrically stimulated dog muscle (12) . In contrast to the delay found in these studies, electrically stimulated rat spinotrapezius muscles (3), the canine gastrocnemius-plantaris complex (13) , and single frog muscle fibers (18) all evidence an increase in muscle V O 2 without apparent delay from the first contraction. Thus, the delayed response of microvascular partial pressure of oxygen (Pmv O 2 ) following the onset of contractions (3, 4) reflects a close matching or balance between O 2 delivery and V O 2 . These investigations support the contention that muscle V O 2 kinetics at exercise onset are subject to mitochondrial rather than O 2 delivery control. However, the precise mechanistic bases for that mitochondrial control and whether AMPK might play an important role therein remains to be resolved.
Although AMPK is considered to be a regulator of nitric oxide metabolism (25, 46) and oxidative phosphorylation (25, 51) , it is unclear whether the dynamic balance of O 2 delivery to uptake at exercise onset is dependent upon AMPK activation level. Therefore we used transgenic mice with muscle-specific inactive AMPK to investigate the potential for a role of skeletal muscle AMPK to regulate Pmv O 2 kinetics following onset of muscle contractions. According to Fick's law, Pmv O 2 sets the driving pressure crucial for blood-myocyte O 2 flux and hence muscle V O 2 kinetics. In the present investigation, we tested the hypothesis that skeletal muscle AMPK helps mediate the balance between oxidative phosphorylation and O 2 supply during muscle contractions. AMPK activity differs according to the specific mode of electrical stimulation (47) . Therefore, both twitch and tetanic contraction protocols, which provide a range of metabolic rates and consequently different arteriovenous O 2 extractions and Pmv O 2 values, were implemented to evaluate a better the role of AMPK in regulating Pmv O 2 kinetics.
MATERIALS AND METHODS
Animals. Transgenic mice were produced expressing a dominantnegative mutant of ␣ 1-AMPK in skeletal muscle (␣1-AMPK-DN mice) as previously described (28) . Briefly, human skeletal muscle ␣-actin promoter provided by Drs. E. D. Hardeman and K. Guven (Children's Medical Research Institute, Westmead, Australia) was used to express ␣ 1-AMPK-DN in skeletal muscle. Using this promoter, expression of transgene was observed only in skeletal muscle tissues (7, 29) . In Northern blot analysis, exogenous AMPK mRNAs were observed only in skeletal muscles from AMPK-DN mice. The activities of ␣ 1-isoform in gastrocnemius were 1.61 Ϯ 0.12 (WT) and 0.67 Ϯ 0.07 pmol·min Ϫ1 ·mg Ϫ1 protein (AMPK-DN). Those of the ␣2-isoform in gastrocnemius were 0.66 Ϯ 0.10 (WT) and 0.02 Ϯ 0.01 pmol·min Ϫ1 ·mg Ϫ1 protein (AMPK-DN). The activities of the ␣1-isoform in liver were 29 Ϯ 3 (WT) and 33 Ϯ 1 pmol·min Ϫ1 ·mg
Ϫ1
protein (AMPK-DN). Those of the ␣2-isoform in liver were 17 Ϯ 3 (WT) and 22 Ϯ 2 pmol·min Ϫ1 ·mg Ϫ1 protein (AMPK-DN). These activity data have been reported previously (28) . Male chimeras (BDF1 background) harboring the ␣1-AMPK-DN transgene were mated with pure C57BL/6J females to obtain F1 offspring. The heterozygous F1 male offspring from this breeding were then backcrossed with purebred C57BL/6J females to obtain F2 offspring, and this process was continued until the F7 generation of mice was obtained. Heterozygous F7 offspring and WT, born at the same period were used for the experiments.
Mice were maintained on a 12:12-h light-dark cycle and received food and water ad libitum. All experiments were conducted under the guidelines established by the Physiological Society of Japan and were approved by University of Electro-Communications Institutional Animal Care and Use Committee.
Experimental protocol. Phosphorescence quenching was utilized for the determination of Pmv O 2 at rest and during contractions within the medial region of the gastrocnemius muscle. Before the surgical procedures, the animals were anesthetized with isoflurane in 100% O2 (50 mg/kg). The mouse was placed on a heating pad (38°C) to maintain body temperature, and the phosphorescent probe [palladium meso-tetra (4-carboxyphenyl) porphyrin dendrimer (R2) at 15 mg/kg body wt] was injected using a 16-gauge needle into the fundi vein. The total duration of the experiments did not exceed 1 h.
After the overlying skin was reflected and fascia were removed, the muscle surface was superfused with Krebs-Henseleit solution equilibrated with 5% CO 2-95% N2 at 38°C and adjusted to pH 7.4. For the induction of muscle contractions in the gastrocnemius muscle, stainless steel electrodes (model TN-200 -214; Unique Medical, Tokyo, Japan) were attached to the tibial nerve. Before stimulation, the ankle and knee joint angle were clamped at 90 degrees and attached to a force transducer (model RU-72; NEC Medical Systems, Tokyo, Japan,). The muscle tension development data were transferred to a microcomputer using data acquisition software (Chart version 3.6.3) at a sampling frequency of 10 kHz.
Pmv O 2 measurements. The phosphor R2 was infused ϳ15 min before the experimental procedure, and all experiments were conducted in a darkened room to prevent contamination from ambient light. After a 10-to 15-min stabilization period following the surgery, twitch (1 Hz, 3-5 V, 4-ms pulse duration) and tetanus (100 Hz, 3-5 V, 4-ms pulse duration, stimulus duration of 100 ms every 1 s) muscle contractions were elicited for 1 min. Pmv O 2 was determined at 1-s intervals at rest, during contractions, and for 1 min of subsequent recovery.
The theoretical basis for phosphorescence quenching has been detailed previously (4, 5, 42) . Briefly, the Stern-Volmer relationship (42) describes quantitatively the O 2 dependence of the phosphorescent probe. R2 is a nontoxic dendrimer (23) that binds completely to albumin at 38°C and pH 7.4, with a quenching constant of 409 mmHg/s and lifetime decay in the absence of O 2 of 601 s (26, 33) . In addition to binding with albumin, the net negative charge of R2 also facilitates restriction of the compound to the vascular space (36) .
Pmv O 2 reflects the PO2 within the capillary blood, which constitutes the principal intramuscular vascular space. To determine Pmv O 2 , a PMOD 2000 frequency domain phosphorometer (Oxygen Enterprises, Philadelphia, PA) was utilized. The common end of the bifurcated light guide was placed ϳ2-3 mm above the medial region of the gastrocnemius muscle, and blood was sampled within the microvasculature up to ϳ500 m deep within a circular region ϳ2 mm in diameter. The phosphorometer employs a sinusoidal modulation of the excitation light (524 nm) at frequencies between 100 Hz and 20 kHz, which allows for phosphorescence lifetime measurements from 10 s to ϳ2.5 ms. In the single-frequency mode, 10 scans (100 ms) were used to acquire the resultant lifetime of the phosphorescence (700 nm) and were repeated every 1 s (for review, see Ref. 48) . To obtain the phosphorescence lifetime, the logarithm of the intensity values was taken at each time point, and the linearized decay was fit to a straight line by the least squares method.
Modeling of PmvO 2 profiles. Curve fitting was accomplished using KaleidaGraph software (version 3.6; Synergy Software, Reading, PA) and was performed on the PmvO 2 data using a one-component model: To determine whether the one-component or the two-component model would best describe the PmvO 2 response for either the WT or AMPK-DN mice, the goodness-of-fit for the model was determined via three criteria: 1) the coefficient of determination (i.e., r 2 ), 2) the sum of the squared residuals term (i.e., 2 ), and 3) visual inspection of the model fit to the data.
Histological evaluation. After the phosphorescence quenching protocols, the ipsilateral gastrocnemius muscle was dissected carefully, and the midbelly region cut transversely to the long axis of the muscle. The tissue blocks were rapidly frozen in isopentane cooled by liquid nitrogen. Transverse cross sections of 10 m were made with a cryostat (model CM1510; Leica) at Ϫ20°C. The sections were stained for measurement of succinate dehydrogenase (SDH) activity and identification of capillaries by using alkaline phosphatase.
The original SDH staining protocol was described by Nishizaka et al. (31) . The SDH activity was determined by incubation in the following medium: 0.9 mM 1-methoxyphenazine methylsulfate, 1.5 mM nitroblue tetrazolium, 5.6 mM ethylenediaminetetraacetic acid disodium salt, and 48 mM succinate disodium salt, pH 7.6 in 100 mM phosphate buffer. The reaction time was 10 min after which it was arrested using distilled water, and subsequently sections were dehydrated in a graded series of ethanol and passed through xylene. The cross-sectional areas and SDH activities were measured by tracing fiber outlines of ϳ70 fibers in the deep and superficial regions of the muscle section. The images were digitized as gray level pictures. Each pixel was quantified as one of 256 gray levels and then automatically converted to optical density using ImageJ software (National Institutes of Health, Bethesda, MD).
The capillary profiles were identified using alkaline phosphatase staining in the capillary endothelium as follows: tissue sections were incubated in a solution containing 2.5 mM naphthol AS-MX phos-phate, 7 mM variamine blue salt RT and 5% N,N-dimethylformamide in 0.1 M Tris·HCl buffer (pH 9.2) at 38°C for 1 h.
Each section was analyzed in a deep and superficial region, and there were 247-602 capillaries in the deep region and 92-248 capillaries in the superficial region identified for each muscle. Capillary density (number/mm 2 ) and capillary-to-fiber ratio were measured directly from images of micrographs projected on a screen.
Statistical analysis. All experimental data are expressed as means Ϯ SE. All statistical analyses were performed in Prism version 4.0 (GraphPad software). Group differences in Pmv O 2 , muscle torque and histological data were determined by a two-way ANOVA and Bonferroni's post hoc test. The level of significance was set at P Ͻ 0.05.
RESULTS
Animal data. Body weights did not differ between WT (37.5 Ϯ 2.4 g) and AMPK-DN mice (38.0 Ϯ 1.0 g; P Ͼ 0.05). There were no differences in maximal isometric force of plantarflexor muscles for AMPK-DN mice (twitch: 29. No significant interaction effect was observed for either parameters or measurements. Figure 2 shows the changes of relative twitch and tetanic force production. There was no significant attenuation of the twitch force during this contractions protocol for WT or AMPK-DN mice. In contrast, there was a progressive attenuation of the tetanic force production in both groups with a significant decrease occurring after 46 -50 s of contractions.
Histological evaluation. Both capillarity and oxidative capacity (as assessed via SDH) demonstrated regional differences within the gastrocnemius muscle ( Fig. 3 and Table 2 ). Specifically, compared with the superficial region capillary density and capillary-to-fiber ratio as well as SDH activity (specific activity and total fiber activity) in the deep region were higher. With respect to AMPK-DN vs. WT, despite the reduced capillary-to-fiber ratio (deep region: Ϫ20.7%; superficial region: Ϫ52.1%), capillary density did not decrease significantly in AMPK-DN, in part, because of the smaller fiber crosssectional area (deep region: Ϫ22.2%; superficial region: Ϫ18.6%), which served to increase fiber numbers per millimeter squared and thus raise capillary density above what would have been found in the absence of fiber atrophy. SDH-specific activity tended to be lower in the AMPK-DN muscle fibers and, because of the fiber atrophy, total SDH activity per fiber was markedly depressed.
DISCUSSION
To our knowledge, this was the first investigation to examine the Pmv O 2 kinetics during transitions from rest to electrically stimulated contractions in transgenic mice in an in vivo model. We hypothesized that skeletal muscle AMPK helps mediate Pmv O 2 kinetics during muscle contractions. The principal original findings with respect to the AMPK-DN condition include the following: 1) prolongation of the time delay before Pmv O 2 begins to decline; and 2) faster time constant for the primary component Pmv O 2 response, which indicates a relatively more rapid V O 2 compared with the O 2 delivery response. This effect likely emanates from a disproportionately larger slowing of O 2 delivery dynamics than mitochondrial oxidative function and supports the notion that both vascular responses and mitochondrial function are compromised in the AMPK-DN muscle. Even in the absence of altered steady-state Pmv O 2 and/or V O 2 these responses would be expected to sow the seeds for subsequent exercise intolerance (41) , which is observed in longer (i.e., ϾϾ1 min) exercise protocols (20, 28, 45) .
Exercise intolerance of AMPK-DN mice. The present investigation used both twitch and tetanic stimulation protocols because AMPK activity is regulated differently in each mode of electrical stimulation and also to provide a range of metabolic rates (twitch Ϫ low, tetanic Ϫ higher) and ⌬ Pmv O 2 s (see Table 1 ). Specifically, it has been reported that twitch contractions activate ␣ 1 -AMPK but not ␣ 2 -AMPK, whereas tetanic contractions activate both ␣ 1 -AMPK and ␣ 2 -AMPK activities (47) . The AMPK-DN mice used in this study exhibit a 50% reduction in ␣ 1 -AMPK activity and almost complete loss of ␣ 2 -AMPK activity compared with WT (28) . Therefore, we expected that contractile performance of AMPK-DN mice would be especially low in the tetanic contraction condition. However, no difference was found between WT and AMPK-DN mice with respect to fatigue during twitch or tetanic stimulations. It has been reported that depletion of AMPK results in exercise intolerance and impaired muscle performance (20, 28) . We have determined that the exercise tolerance for low speed (10 m/min) running did not differ between WT and AMPK-DN mice, whereas it was markedly impaired for AMPK-DN mice at high speed (30 m/min) (28) . Thus, the compromised exercise tolerance of AMPK-DN mice may be limited to high-intensity exercise that either might not have been replicated by the contractile challenges presented herein (i.e., either twitch or tetanic contractions) or alternatively might only be revealed by longer bouts of exercise stress. In this regard, it is pertinent that the lower capillary-tofiber ratio and reduced SDH activity per muscle fiber in the AMPK-DN muscles may also act to impair exercise tolerance during more prolonged exercise.
Initial delay in Pmv O 2 fall in AMPK-DN mice. As discussed in the INTRODUCTION, it is now recognized that muscle V O 2 increases following the onset of muscle contractions without discernible delay (3, 13, 18) . However, the factor(s) controlling V O 2 kinetics during exercise are incompletely understood (35, 49) . Pmv O 2 is determined by the relationship between capillary O 2 delivery and mitochondria V O 2 . Therefore the tracking of Pmv O 2 dynamics during muscle contractions facilitates resolution of the O 2 supply to V O 2 balance and the upstream O 2 partial pressure driving blood-myocyte O 2 flux. In healthy animals in response to twitch muscle contractions, Pmv O 2 demonstrates a distinct time delay [the magnitude of which is dependent, in part, upon muscle fiber type (6, 27)] followed by an exponential fall to steady state (3, 4, 37) . Mathematically and in accordance with the principles of mass balance if V O 2 is increasing exponentially simultaneously with contractions onset (3), the initial delay component (where Pmv O 2 remains essentially unchanged) must result from an equal increase of O 2 delivery and V O 2 (19, 38) . The extension of this time delay in AMPK-DN mice may be due to a slower increase of mitochondrial V O 2 . It has been reported that AMPK regulates oxidative phosphorylation via peroxisome proliferator-activated receptor-␥ coactivator (PCG-1␣) (16, 32) , and direct experimental evidence indicates that the PCG-1␣ increases V O 2 in differentiated myotubes (50) . Although AMPK does not directly regulate pyruvate dehydrogenase phosphorylation and activity in murine skeletal muscle, lack of AMPK may decrease mitochondria oxidative capacity (20) . The present investigation is the first to suggest that AMPK contributes to Pmv O 2 and muscle V O 2 kinetics control during contractions in vivo.
Dynamic profile of Pmv O 2 in AMPK-DN mice. During contractions and following the time-delay phase (i.e., matched O 2 supply-to-consumption ratio) Pmv O 2 falls exponentially (Fig.   1 ), which occurs as fractional O 2 extraction increases and accordingly venous O 2 content is decreased. The Pmv O 2 fall results from the rise in V O 2 proportionally exceeding that of muscle capillary O 2 delivery (i.e., decreased O 2 delivery-to-V O 2 ratio). In young healthy animals, the Pmv O 2 kinetics allow Pmv O 2 to stabilize at a lower level reflecting the full magnitude of the increased fractional O 2 extraction evoked by the contractions protocol and the O 2 delivery-to-V O 2 balance (9, 39). That Pmv O 2 does not fall precipitously to undershoot the steady-state, at least during twitch contractions, supports the contention that O 2 supply itself is not a limiting factor for oxidative phosphorylation or muscle V O 2 kinetics (4, 37, 38) .
In AMPK-DN mice, the kinetics of Pmv O 2 fall following the time-delay phase was steeper than for WT (i.e., shorter time constant, ). This phenomenon may be associated with im- A: stained for alkaline phosphatase. B: stained for succinate dehydrogenase activity (SDH). Scale bars ϭ 50 m. Note that the capillary-tofiber ratio and total fiber SDH activity were reduced in AMPK-DN compared with WT muscles (see Table 2 ). paired vasomotor function, possibly related to neuronal nitric oxide synthase (nNOS) deficits, as it has been shown that expression of skeletal muscle nNOS isoform and exercise hyperemia response are deficient in AMPK-DM mice (25) . In vivo experiments confirmed that NO-dependent vascular relaxation in contracting skeletal muscle may require both nNOS and endothelial NOS (24) . Moreover, acute nNOS blockade results in a faster Pmv O 2 fall following the onset of twitch contractions in the rat spinotrapezius muscle despite a reduced muscle V O 2 (8) . Therefore the reduced nNOS expression during muscle contractions may potentially have suppressed arteriolar dilation in AMPK-DN mice.
Characteristics of capillarization and oxidative enzyme activity. Mitochondrial volume density, as quantified by electron microscopy, does not change in AMPK-DN mice (51) . On the other hand, there is a decrease of specific oxidative enzyme function. For instance, in the electron transport chain complex I and IV (but not complex II) activities are impaired in the gastrocnemius muscle of AMPK-DN mice (25) . In agreement with these findings, there was no difference in global SDH activity (i.e., complex II) among groups. However, total SDH activity per muscle fiber, which is considered the relevant functional property, was reduced significantly primarily consequent to the muscle atrophy present in AMPK-DM mice (Table 2) .
Recently, Zwetsloot et al. (52) have demonstrated that AMPK regulates the maintenance of basal capillarity and VEGF expression in skeletal muscle. In the present investigation, capillary density did not differ between the WT and AMPK-DN mice. However, a significantly decreased capillary-to-fiber ratio (i.e., decrease of the capillary absolute number) was found in the AMPK-DN mice. As blood flow and, therefore, O 2 delivery is determined at the arteriolar and not capillary level, the change of Pmv O 2 kinetics observed with AMPK-DN mice may be related to an impaired vasodilatory function rather than morphological vascular alterations per se. However, for any equivalent metabolic rate (V O 2 ) and blood flow, at the same capillary hematocrit, the loss of capillaries will reduce the number of red blood cells adjacent to the contracting myocytes, which is the key determinant for muscle O 2 diffusing capacity (for discussions, see Refs. 19 and 37) .
Physiological role of AMPK following contractions onset. During the course of muscle contractions, the rate of ATP turnover may increase more than 100 times compared with rest. Therefore the ATP resynthesis pathways need to be activated immediately to avoid decreasing [ATP] . Oxidative phosphorylation is enhanced simultaneously with the onset of muscle contractions (3, 13, 18) , and the response occurs in parallel to anaerobic ATP resynthesis pathways (21) .
Some models of the control of oxidative phosphorylation incorporate increments of ADP, P i , and NADH-to-NAD ratio. It is suggested, however, that the change of these metabolite concentrations at the onset of muscle contractions is insufficient to activate oxidative phosphorylation (21) . It is also pertinent that the O 2 supply system elevates capillary red blood cell transport simultaneously [i.e., in the first contractionrelaxation cycle, (19) ] in concurrence with muscle contraction. Multiple mechanical (i.e., muscle pump), neural (i.e., conducted vasodilation), and metabolic (sympatholysis, vasodilatory metabolites) mechanisms as well as rapid vasodilation of unknown origin are recognized as contributing to the exercise hyperemia. However, the manner in which O 2 delivery is, in the majority of circumstances, so precisely matched to O 2 utilization (as indicated by the intransigent Pmv O 2 during the time delay) remains to be resolved. AMPK is activated by the AMP-to-ATP ratio, (44) . Recent reports (25) confirm that AMPK has essential biological effects on both mitochondrial and vascular function. In addition to existing literature (25) , the present investigation has determined, for the first time by analysis of the Pmv O 2 profile following the onset of contractions in vivo, that AMPK has a direct impact on the nonsteady-state O 2 supply-to-V O 2 balance following the onset of contractions.
Experimental considerations. The Pmv O 2 signal is a volumeweighted average of all vessels sampled. Large vessels (arteries, arterioles, venules, veins) where visible to the naked eye are specifically avoided and hence sampling is restricted to microvessels (small arterioles, capillaries, venules). Because, within skeletal muscle, a greater volume of blood is expected to reside toward the venous end of the capillary and in small venules, the Pmv O 2 will be most heavily weighted toward venous PO 2 values. However, following the onset of contractions there is likely to be an altered distribution of volume as arterioles dilate, thereby acting to raise Pmv O 2 . In addition, any precapillary O 2 losses seen at rest that would lower arteriolar (and capillary PO 2 ) (34) are expected to decrease as red blood cell velocity and flux through these vessels increases, also acting to increase the measured Pmv O 2 . The extent of these two effects to modulate the observed Pmv O 2 profile with contractions remains to be determined.
Perspectives and Significance
The present findings are consistent with the presence of mitochondrial and microvascular dysfunction in AMPK-DN mice, which slows V O 2 kinetics (i.e., oxidative phosphorylation response, as suggested by the increased time delay prior to the Pmv O 2 fall) and impairs the hyperemic response (as indicated Values are means Ϯ SE. CD, capillary density; CF ratio, capillary-to-fiber ratio; SDH, succinate dehydrogenase, total SDH ϭ SDH ϫ fiber area; OD, optical density. n ϭ 6.
